Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 9.76M P/E - EPS this Y 36.10% Ern Qtrly Grth -
Income -7.12M Forward P/E -1.64 EPS next Y -27.20% 50D Avg Chg -14.00%
Sales - PEG - EPS past 5Y - 200D Avg Chg -63.00%
Dividend N/A Price/Book 1.09 EPS next 5Y - 52W High Chg -85.00%
Recommedations 2.00 Quick Ratio 6.53 Shares Outstanding 3.52M 52W Low Chg 10.00%
Insider Own 53.29% ROA -53.45% Shares Float 1.64M Beta 1.16
Inst Own 2.38% ROE -102.31% Shares Shorted/Prior 652.49K/29.81K Price 0.74
Gross Margin - Profit Margin - Avg. Volume 390,070 Target Price 18.00
Oper. Margin - Earnings Date Nov 7 Volume 54,493 Change 1.79%
About Monopar Therapeutics Inc.

Monopar Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics for the treatment of cancer in the United States. The company develops MNPR-101-Zr, a clinical stage urokinase plasminogen activator receptor-targeted radiodiagnostic imaging agent; and MNPR-101-RIT, a late preclinical stage radiotherapeutic for advanced cancers. It also develops Camsirubicin, a Phase 1b clinical stage novel analog of doxorubicin, which is in Phase 1b clinical trial for the treatment of advanced soft tissue sarcoma; and MNPR-202, an analog of Camsirubicin to treat doxorubicin-and camsirubicin-resistant cancers. Monopar Therapeutics Inc. has collaborations NorthStar to develop radio-immuno-therapeutics targeting severe COVID-19; and the Cancer Science Institute of Singapore to evaluate the activity of MNPR-202 and related analogs in various types of cancer. The company was founded in 2014 and is headquartered in Wilmette, Illinois. Monopar Therapeutics Inc. is a subsidiary of Tacticgem LLC.

Monopar Therapeutics Inc. News
11/08/24 Monopar Therapeutics Reports Third Quarter 2024 Financial Results and Recent Developments
10/30/24 Monopar Therapeutics Inc. Announces Closing of $19.2 Million Public Offering of Common Stock
10/28/24 Monopar Therapeutics Inc. Announces Pricing of $19.2 Million Public Offering of Common Stock
10/28/24 Monopar Therapeutics Inc. Announces Proposed Public Offering of Common Stock
10/26/24 Individual investors are Monopar Therapeutics Inc.'s (NASDAQ:MNPR) biggest owners and were rewarded after market cap rose by US$40m last week
10/25/24 Monopar Therapeutics Secures License for Wilson Disease Treatment
10/24/24 Monopar Announces Agreement with Alexion, AstraZeneca Rare Disease For Late-Stage Wilson Disease Drug Candidate
10/22/24 Monopar Presents Encouraging Human Clinical Dosimetry Data on its uPAR Program at EANM 2024
10/16/24 Monopar Therapeutics Expands Portfolio with New Patent Filing
10/15/24 Monopar Expands Radiopharma Intellectual Property Portfolio with Patent Filing on New Compounds and Linkers
10/08/24 Monopar Therapeutics Launches Phase 1a uPAR-Targeted Cancer Trial
10/07/24 Monopar Initiates Clinical Trial of Novel uPAR-Targeted Radiopharmaceutical Therapy in Advanced Cancers
09/12/24 Monopar Announces Positive Early Human Clinical Data Validating the Tumor Targeting Ability of MNPR-101-Zr
09/04/24 Monopar to Participate in the H.C. Wainwright 26th Annual Global Investment Conference
08/27/24 Monopar Regains Compliance with Nasdaq Minimum Bid Price Rule
07:00 AM Monopar Receives Clearance to Proceed with Phase 1 Therapeutic Trial of Novel Radiopharmaceutical in Advanced Cancers
08/14/24 Monopar Announces Initial Data for First Patient Dosed in Radiopharma Phase 1 Clinical Trial of MNPR-101-Zr
08/13/24 Here's Why We're Watching Monopar Therapeutics' (NASDAQ:MNPR) Cash Burn Situation
08/12/24 Upcoming Stock Splits This Week (August 12 to August 16) – Stay Invested
08/09/24 Monopar Therapeutics Announces 1-for-5 Reverse Stock Split
MNPR Chatroom

User Image shift_4 Posted - 14 hours ago

$ENSC hahaha did RA buy this and go short? is that why you're here trying to FUD people out of here and bag them into $MNPR as its chart flips over? Or are you guys just scalping a bit and trying to fully reload? -$

User Image shift_4 Posted - 14 hours ago

@scammmer1 interesting that you're a hedger affiliated with an HC Wainright client. I wonder if it's Sabby or Lincoln Park Capital. I bet I'll figure out myself in the next 10-15mins. Enjoy the dump at $MNPR

User Image scammmer1 Posted - 14 hours ago

$ENSC $MNPR 🤷 called it

User Image Metrading29 Posted - 15 hours ago

$MNPR looks like a runner today. Lets see if it can cross $30 this week.🚀🚀🚀

User Image Doozio Posted - 15 hours ago

$MNPR lets huckleberry ride INTA 🧠⏰♾️

User Image student56 Posted - 15 hours ago

$MNPR where are bulls. Why no volume. Such good stock with price target 37$

User Image Biotech2424 Posted - 16 hours ago

Tang building position in Coherus. Everyone made 100-400% when he started building his position in Monopar last month. He co-founded Heron which is similar to this. This checkpoint inhibitor that’s fda approved at Coherus has massive upside. $CHRS $MNPR

User Image Alonalon Posted - 16 hours ago

$MNPR 🔥🔥🔥

User Image AbnerWaller Posted - 18 hours ago

$NISN $MNPR LFG, expected this to move higher. Also, your thoughts on MYNZ? Who's behind the 30M share offering deal? 👀 And how could the Thermo Fisher (TMO) partnership ($210B market cap) reflect this stock movement and PR buzz everywhere on socials?

User Image vjtweet Posted - 1 day ago

$MNPR holding a small position.

User Image RiskBreaker4M Posted - 1 day ago

$MNPR

User Image student56 Posted - 1 day ago

$MNPR where are buyers. It is target price 37$

User Image Stocksrockman Posted - 3 days ago

$DRUG $MNPR $SMMT $UPXI $ZONE Zone could be DRUG money

User Image Bobby__Slapselrod Posted - 4 days ago

$ZONE life changing money here on Monday. $drug changed my life $MNPR changed my life $SUGP helped me $PLTR helped put money 🤑 in my pockets ZONE is next

User Image VMAESA Posted - 4 days ago

$MNPR Stop✋ looking at those pointless “alerts” when your clueless furu’s cant show you results like these👇 Follow & use the link in bio to join the BEST community on this planet🥳

User Image posned Posted - 5 days ago

$MNPR up in a red market nice

User Image student56 Posted - 5 days ago

$MNPR UPPPP!!!

User Image tradingg_journey Posted - 5 days ago

$MNPR about to skyrocket, low float, former runner, broke the resistance of 18,

User Image DirtMover Posted - 5 days ago

$MNPR ave is like $5’s

User Image student56 Posted - 5 days ago

$MNPR smelling 50$

User Image MrGuttenburg Posted - 5 days ago

$MNPR let's go!!! 20??!!!

User Image Johnmtnb2018 Posted - 5 days ago

$SLS $SMMT $MNPR $SGMO Only Listen to the Doctors who are treating actual patients in the GPS REGAL Phase 3 Registrational trial in AML CR2: “As a principal investigator from a high enrolling REGAL study site, I am of course delighted to learn that the interim analysis, a key milestone, is upcoming," said Panagiotis Tsirigotis, MD, Professor of Medicine at the University of Athens and Chief of Leukemia at Attikon University Hospital. "What makes me equally and perhaps even more excited is that now with the REGAL study enrollment completed and upcoming efficacy read-out, I am looking forward to the potential expansion of GPS into other settings, beyond maintenance of second remissions in patients with AML, as it could function as a treatment modality in patients in first remission as well as post bone marrow transplant." ***Current MC 78 M, After IDMC halt due to overwhelming efficacy = $6 Billion= $100.00+

User Image Metrading29 Posted - 5 days ago

$CHRS $DRG $MNPR $PYXS last week you were bashing about $CLRB. I don’t see your comments about it anymore. Anything changed?

User Image Biotech2424 Posted - 5 days ago

$CHRS $DRG $MNPR $PYXS

User Image Biotech2424 Posted - 5 days ago

Baby Keytruda at Coherus shorts going to burn 🔥 $CHRS $MRK $CTMX $MNPR

User Image Paper_Route_Frank Posted - 6 days ago

$MNPR looks ready

User Image Biotech2424 Posted - 6 days ago

$CHRS (Reversion to Mean short position +93.75% upside in next 90 Days in Coherus stock) The Average short position past 12 mos is: 24,568,554 so we are 7,000,000 shares more than average. Last time we were trading at between 24,000,000 and 25,000,000 short was August 15th to August 30th.. The stock peaked at $1.55 per share on August 15th. Therefore, we have 75 cents of upside in Coherus once we get back to the average short range or 93.75% upside. Considering revenues were robust that's our upside in 90 days. https://www.nasdaq.com/market-activity/stocks/chrs/short-interest $MNPR $PYXS $DRG

User Image rangervs Posted - 6 days ago

$MNPR shake some weak hands out

User Image Trent_Carey Posted - 6 days ago

$CATX $MNPR $IMNM $PYXS

User Image Hallochen Posted - 1 week ago

$ELAB $QLGN Soon news from the lab🥳🥳🥳 it will fly like $MNPR🚀🚀🚀 700%💪🏻💪🏻💪🏻

Analyst Ratings
HC Wainwright & Co. Buy Aug 14, 24
HC Wainwright & Co. Buy May 10, 24
JonesTrading Buy Apr 11, 24
HC Wainwright & Co. Buy Jun 1, 23
HC Wainwright & Co. Buy May 15, 23
Maxim Group Hold Mar 29, 23
EF Hutton Buy Mar 28, 23
EF Hutton Buy Mar 24, 23
HC Wainwright & Co. Buy Feb 15, 23
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Cittadine Andrew Chief Operating Offi.. Chief Operating Officer Nov 14 Buy 3.08 16,053 49,443 24,238 11/16/22